Skip to main
DLB

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories is well-positioned for future revenue growth due to its diversity in revenue sources, especially with its licensing operations that generate the majority of its revenue. The company is also expanding its opportunities for monetization through new applications and SaaS-like models, and its strong base of Atmos, Vision, and imaging patents with outlook for 15-20% growth. The company is also mitigating the impact of the macro environment on its foundational revenues through minimum volume commitments, while its investments in Atmos and Vision technologies are expected to drive long-term growth potential for Dolby.

Bears say

Dolby Laboratories is facing a challenging environment with limited end demand for its high-quality audio and imaging technologies, resulting in flat revenue growth. The company's strong market position and cash flows provide stability, but without a significant improvement in overall demand, growth may be unlikely in the near term. While there are potential sources of incremental revenue, such as its VDP and OptiView technologies, their impact may not be enough to drive significant growth without a favorable market environment.

Dolby Laboratories (DLB) has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 3 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Aug 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.